SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-001810
Filing Date
2022-02-24
Accepted
2022-02-23 21:48:01
Documents
104
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clvs-20211231x10k.htm   iXBRL 10-K 4127879
2 EX-23.1 clvs-20211231xex23d1.htm EX-23.1 5358
3 EX-31.1 clvs-20211231xex31d1.htm EX-31.1 15710
4 EX-31.2 clvs-20211231xex31d2.htm EX-31.2 15748
5 EX-32.1 clvs-20211231xex32d1.htm EX-32.1 6449
6 EX-32.2 clvs-20211231xex32d2.htm EX-32.2 6486
7 GRAPHIC clvs-20211231x10k006.jpg GRAPHIC 74407
8 GRAPHIC clvs-20211231x10k008.jpg GRAPHIC 60702
  Complete submission text file 0001558370-22-001810.txt   16026732

Data Files

Seq Description Document Type Size
9 EX-101.SCH clvs-20211231.xsd EX-101.SCH 80172
10 EX-101.CAL clvs-20211231_cal.xml EX-101.CAL 105683
11 EX-101.DEF clvs-20211231_def.xml EX-101.DEF 304976
12 EX-101.LAB clvs-20211231_lab.xml EX-101.LAB 744512
13 EX-101.PRE clvs-20211231_pre.xml EX-101.PRE 562678
98 EXTRACTED XBRL INSTANCE DOCUMENT clvs-20211231x10k_htm.xml XML 3340337
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35347 | Film No.: 22666233
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences